SCHEMBL3263075

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL7914657	0.81	CA12 (0.36)	CA12CA1CA2CA9HSD11B1
	SCHEMBL3260368	0.78	—	—
	SCHEMBL10521431	0.66	NPC1 (0.48)	CA12CA1CA2CA9NPC1
	SCHEMBL8436667	0.65	NPC1 (0.53)	CA1CA2CA9NPC1TP53
	SCHEMBL10522363	0.62	NPC1 (0.50)	CA12CA1CA2CA9NPC1
	SCHEMBL10519327	0.62	HPGD (0.71)	CA1CA2CA9NPC1TP53
	SCHEMBL10516550	0.61	HPGD (0.59)	CA1CA2CA9NPC1TP53
	SCHEMBL3260322	0.61	—	—
	SCHEMBL10514954	0.60	NPC1 (0.45)	CA12CA1CA2CA9NPC1
	SCHEMBL10555587	0.59	HPGD (0.54)	CA12CA1CA2CA9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.